Difference between revisions of "SMARCA4"
Jump to navigation
Jump to search
(+sinonasal) |
|||
| Line 3: | Line 3: | ||
*[[SMARCA4-deficient pulmonary adenocarcinoma]]. | *[[SMARCA4-deficient pulmonary adenocarcinoma]]. | ||
*[[Ovarian small cell carcinoma of the hypercalcemic type]]. | *[[Ovarian small cell carcinoma of the hypercalcemic type]]. | ||
*SMARCA4-deficient sinonasal carcinoma.<ref>{{cite journal |authors=Kakkar A, Ashraf SF, Rathor A, Adhya AK, Mani S, Sikka K, Jain D |title=SMARCA4/BRG1-Deficient Sinonasal Carcinoma |journal=Arch Pathol Lab Med |volume=146 |issue=9 |pages=1122–1130 |date=September 2022 |pmid=34871352 |doi=10.5858/arpa.2021-0001-OA |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 14:16, 6 October 2023
SMARCA4, also BRG1,[1] is a gene mutated in:
- Atypical teratoid/rhabdoid tumour.
- SMARCA4-deficient pulmonary adenocarcinoma.
- Ovarian small cell carcinoma of the hypercalcemic type.
- SMARCA4-deficient sinonasal carcinoma.[2]
References
- ↑ Online 'Mendelian Inheritance in Man' (OMIM) 603254
- ↑ Kakkar A, Ashraf SF, Rathor A, Adhya AK, Mani S, Sikka K, Jain D (September 2022). "SMARCA4/BRG1-Deficient Sinonasal Carcinoma". Arch Pathol Lab Med 146 (9): 1122–1130. doi:10.5858/arpa.2021-0001-OA. PMID 34871352.